Christine Aylward

Solo GP · Miami Beach, FL

Verified active in the last 12 months

Christine Aylward is a solo GP based in Miami Beach, FL focused on Biotech & Pharma, B2B Software, investing at seed to series b stage. Christine Aylward's most recent fund with a disclosed size, Magnetic Ventures FUND II LP, filed a $100M offering with the SEC in Dec 2023. Christine Aylward has 2 funds and deal vehicles on SEC file. Estimated typical check: $1M–$3M. Christine Aylward has dated investing activity in the last 12 months (latest Mar 2026).

Why Christine Aylward is listed

Named as the only individual (MANAGER OF GENERAL PARTNER OF ISSUER) on the Form D for Magnetic Ventures FUND II LP, a $100M venture fund (Dec 2023) (2 vehicles on file). Also a non-executive director at 3 startups that filed Form D.

Source: SEC Form D: Magnetic Ventures Fund III, L.P. (Mar 30, 2026) · 4 more sources

Is this you? Remove or correct this profile.

Stages: Seed to Series B
Typical check (est.): $1M–$3M
Latest fund: $100M · Dec 2023
Latest dated activity: Mar 2026

Is Christine Aylward a fit for you?

See your fit score and the reason, contact details, and any warm path from your network.

Start 3-day trial to see contacts

What does Christine Aylward invest in?

Biotech & PharmaB2B Software

What has Christine Aylward invested in recently?

Magnetic Ventures Fund III, L.P.
Invested through a fund
Mar 2026
Relation Therapeutics
Board seat on the company's SEC filing (not by itself proof of an investment) · FL
Jan 2024
Magnetic Ventures FUND II LP
Invested through a fund
Dec 2023
Amydis
Board seat on the company's SEC filing (not by itself proof of an investment) · CA
Dec 2023
Weave Platform
Board seat on the company's SEC filing (not by itself proof of an investment) · CT
Dec 2023

Funds and deal vehicles Christine Aylward filed with the SEC

Magnetic Ventures Fund III, L.P.
Fund
Mar 2026
Magnetic Ventures FUND II LP
Fund · $100M offering
Dec 2023

Sources

SEC Form D: Magnetic Ventures Fund III, L.P.Mar 30, 2026
SEC Form D: Magnetic Ventures FUND II LPDec 29, 2023
SEC Form D (board seat): Weave PlatformDec 22, 2023
SEC Form D (board seat): AmydisDec 28, 2023
SEC Form D (board seat): Relation TherapeuticsJan 19, 2024

Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.